Published on 17 Mar 2024 on Simply Wall St. via Yahoo Finance
Estimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT)
Key Insights
Using the 2 Stage Free Cash Flow to Equity, Vaxart fair value estimate is US$0.90With US$1.08 share price, Vaxart appears to be trading close to its estimated fair value The US$5.00 analyst price target for VXRT is 455% more than our estimate of fair value
Today we will run through one way of estimating the intrinsic value of Vaxart, Inc. (NASDAQ:VXRT) by taking the expected future cash flows and discounting them to their present value. Our analysis will employ the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex.